AUSTEDO® XR (deutetrabenazine) extended-release tablets is the first medication approved to treat both tardive dyskinesia and Huntington's disease chorea. See safety info including Boxed Warning.

Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more

AUSTEDO XR and AUSTEDO can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington’s disease. Balance the risks of depression and suicidality with …

Jun 3, 2024 · Austedo (deutetrabenazine) is an approved therapy, also available in an extended-release formulation, for chorea in Huntington's disease.

Jun 26, 2024 · What is Austedo used for? Austedo is commonly used for the following conditions. Chorea, which is a movement disorder that is associated with Huntington’s disease Tardive …

Austedo is a prescription medication that is used to treat the involuntary movements (chorea) of Huntington's disease. The most common side effects of Austedo in people with tardive dyskinesia …

AUSTEDO can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington’s disease. Anyone considering the use of AUSTEDO must balance the risks …

Dec 18, 2025 · Learn about uses, side effects, and more for Austedo (deutetrabenazine), a drug that treats tardive dyskinesia and chorea related to Huntington’s disease.

Jan 19, 2026 · The medications approved by the Food and Drug Administration (FDA) for treating Huntington’s disease chorea are Xenazine (tetrabenazine), Ingrezza (velbenazine) and Austedo …

Summary of Black Box Warnings Depression and Suicidal Thoughts in Patients with Huntington Disease Deutetrabenazine can increase the risk of depression and suicidal thoughts in patients with …